Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2014, Article ID 468925, 8 pages
http://dx.doi.org/10.1155/2014/468925
Research Article

Identification of Posttranslational Modifications in Peroxisome Proliferator-Activated Receptor γ Using Mass Spectrometry

1Institute of Molecular and Cellular Biosciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan
2Department of Molecular Endocrinology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan

Received 31 March 2014; Accepted 19 May 2014; Published 25 June 2014

Academic Editor: Elisabetta Mueller

Copyright © 2014 Shogo Katsura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Tontonoz and B. M. Spiegelman, “Fat and beyond: the diverse biology of PPARgamma,” Annual Review of Biochemistry, vol. 77, pp. 289–312, 2008. View at Google Scholar
  2. I. A. Voutsadakis, “Peroxisome proliferator-activated receptor γ (PPARγ) and colorectal carcinogenesis,” Journal of Cancer Research and Clinical Oncology, vol. 133, no. 12, pp. 917–928, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Xu and Q. Li, “Review of the in vivo functions of the p160 steroid receptor coactivator family,” Molecular Endocrinology, vol. 17, no. 9, pp. 1681–1692, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. G. Rosenfeld, V. V. Lunyak, and C. K. Glass, “Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response,” Genes and Development, vol. 20, no. 11, pp. 1405–1428, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ricote and C. K. Glass, “PPARs and molecular mechanisms of transrepression,” Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids, vol. 1771, no. 8, pp. 926–935, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. E. Floyd and J. M. Stephens, “Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ,” Biochimica et Biophysica Acta. Molecular Basis of Disease, vol. 1822, no. 7, pp. 1090–1095, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Hu, J. B. Kim, P. Sarraf, and B. M. Spiegelman, “Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ,” Science, vol. 274, no. 5295, pp. 2100–2103, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Zhang, J. Berger, G. Zhou et al., “Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ,” Journal of Biological Chemistry, vol. 271, no. 50, pp. 31771–31774, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. H. S. Camp and S. R. Tafuri, “Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase,” Journal of Biological Chemistry, vol. 272, no. 16, pp. 10811–10816, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. H. S. Camp, S. R. Tafuri, and T. Leff, “c-Jun N-terminal kinase phosphorylates peroxisome proliferator- activated receptor-γ1 and negatively regulates its transcriptional activity,” Endocrinology, vol. 140, no. 1, pp. 392–397, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Adams, M. J. Reginato, D. Shao, M. A. Lazar, and V. K. Chatterjee, “Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site,” Journal of Biological Chemistry, vol. 272, no. 8, pp. 5128–5132, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Pascual, A. L. Fong, S. Ogawa et al., “A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ,” Nature, vol. 437, no. 7059, pp. 759–763, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. J. Sims III and D. Reinberg, “Is there a code embedded in proteins that is based on post-translational modifications?” Nature Reviews Molecular Cell Biology, vol. 9, no. 10, pp. 815–820, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. C. T. Walsh, S. Garneau-Tsodikova, and G. J. Gatto Jr., “Protein posttranslational modifications: the chemistry of proteome diversifications,” Angewandte Chemie, vol. 44, no. 45, pp. 7342–7372, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Seo, J. Jeong, M. K. Young, N. Hwang, E. Paek, and K.-J. Lee, “Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase,” Journal of Proteome Research, vol. 7, no. 2, pp. 587–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Yokoyama, S. Katsura, R. Ito et al., “Multiple post-translational modifications in hepatocyte nuclear factor 4α,” Biochemical and Biophysical Research Communications, vol. 410, no. 4, pp. 749–753, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. R. Farley and A. J. Link, “Identification and quantification of protein posttranslational modifications,” Methods in Enzymology, vol. 463, pp. 725–763, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Ahrné, M. Müller, and F. Lisacek, “Unrestricted identification of modified proteins using MS/MS,” Proteomics, vol. 10, no. 4, pp. 671–686, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Smith and A. Shilatifard, “The chromatin signaling pathway: diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes,” Molecular Cell, vol. 40, no. 5, pp. 689–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Yanase, T. Yashiro, K. Takitani et al., “Differential expression of PPAR γ1 and γ2 isoforms in human adipose tissue,” Biochemical and Biophysical Research Communications, vol. 233, no. 2, pp. 320–324, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Sprung, Y. Chen, K. Zhang et al., “Identification and validation of eukaryotic aspartate and glutamate methylation in proteins,” Journal of Proteome Research, vol. 7, no. 3, pp. 1001–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Shu, B. Wong, G. Zhou et al., “Activation of PPARα or γ reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells,” Biochemical and Biophysical Research Communications, vol. 267, no. 1, pp. 345–349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Fujisawa, A. Nakajima, N. Fujisawa et al., “Peroxisome proliferator-activated receptor γ (PPARγ) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the β-catenin/T cell factor (TCF) pathway,” Journal of Pharmacological Sciences, vol. 106, no. 4, pp. 627–638, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Komander and M. Rape, “The ubiquitin code,” Annual Review of Biochemistry, vol. 81, pp. 203–229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. H. Choi, A. S. Banks, J. L. Estall et al., “Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ 3 by Cdk5,” Nature, vol. 466, no. 7305, pp. 451–456, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. H. Choi, A. S. Banks, T. M. Kamenecka et al., “Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation,” Nature, vol. 477, no. 7365, pp. 477–481, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Ji, S. Y. Park, J. Roth, H. S. Kim, and J. W. Cho, “O-GlcNAc modification of PPARγ reduces its transcriptional activity,” Biochemical and Biophysical Research Communications, vol. 417, no. 4, pp. 1158–1163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Hauser, G. Adelmant, P. Sarraf, H. M. Wright, E. Mueller, and B. M. Spiegelman, “Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation,” Journal of Biological Chemistry, vol. 275, no. 24, pp. 18527–18533, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. G. E. Kilroy, X. Zhang, and Z. E. Floyd, “PPAR-γ AF-2 domain functions as a component of a ubiquitin-dependent degradation signal,” Obesity, vol. 17, no. 4, pp. 665–673, 2009. View at Publisher · View at Google Scholar · View at Scopus